Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.xphs.2020.12.025 | DOI Listing |
Can Med Educ J
December 2024
Professor Emeritus, University of Saskatchewan, Saskatchewan, Canada.
Brain Neurosci Adv
January 2025
Academic Faculty, Royal College of Psychiatrists, London, UK.
Policy Polit Nurs Pract
February 2025
Senior Associate Editor, Policy, Politics & Nursing Practice.
Gynecol Oncol
January 2025
Department of Pathology of UFCSPA and Department of Pathology of Irmandade de Santa Casa de Misericórdia de Porto Alegre (ISCMPA), Brazil.
Objective: To evaluate the efficacy of actinomycin D (ActD) as prophylactic chemotherapy (P-chem) in patients with high-risk complete hydatidiform mole (Hr-CHM) on progression to gestational trophoblastic neoplasia (GTN).
Methods: From 1996 to 2023, 426 Hr-CHMs were selected in a cohort of 1623 patients with gestational trophoblastic disease (GTD). From 1996 to 2023, 290 patients with Hr-CHMs received a single bolus dose of Act-D at the time of uterine evacuation (Hr-CHM P-chem group); 136 with the same risk factors did not receive P-chem (Hr-CHM control group).
Acad Radiol
January 2025
Professor of Radiology Northwestern University, Feinberg School of Medicine, 676 N. St. Clair, Suite 800, Chicago, IL 60611. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!